ECM
TTOO

ExodusPoint Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

ExodusPoint Capital Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10
Closed -$47K – 2714
2021
Q3 		$47K Buy
10
+2
+25% +$10.1K ﹤0.01% 1975
2021
Q2 		$45K Sell
8
-33
-80% -$213K ﹤0.01% 2230
2021
Q1 		$334K Buy
41
+25
+156% +$265K ﹤0.01% 1596
2020
Q4 		$99K Buy
+16
New +$97.9K ﹤0.01% 1833

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

ExodusPoint Capital Management's TTOO Position: Q4 2021 in Review

ExodusPoint Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q4 2021, closing a stake of 10 shares — an estimated $47K sold.

ExodusPoint Capital Management first reported a position in TTOO in Q4 2020 and held it in 4 quarters. The position peaked at $334K in Q1 2021. 70 funds tracked by Wall St. Rank hold TTOO as of Q4 2021.

  • ExodusPoint Capital Management reported no remaining T2 Biosystems, Inc position as of Q4 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 10 T2 Biosystems, Inc shares in Q4 2021, an estimated $47K.
  • ExodusPoint Capital Management first reported a position in T2 Biosystems, Inc in Q4 2020 and held it in 4 quarters.
  • ExodusPoint Capital Management's T2 Biosystems, Inc position peaked at $334K in Q1 2021.
  • 70 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.